• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Su­per­nus’ stock sinks af­ter place­bo ef­fect de­rails mid-stage de­pres­sion study

3 months ago
R&D

Pfiz­er’s man­u­fac­tur­ing arm at risk from Trump tar­iffs in Eu­rope, Bourla says

3 months ago
Pharma
Manufacturing

Ex­clu­sive: CRISPR de­liv­ery start­up, based on UC Berke­ley and UCSF sci­ence, shuts down

3 months ago
Startups
R&D

For­mer FDA chief calls job cuts ‘hap­haz­ard, poor­ly thought-out’

3 months ago
Pharma
Diagnostics

NIH pay­ment cuts are 'rea­soned and ra­tio­nal,' gov­ern­ment says

3 months ago
Pharma
Law

No­vo looks to re­coup $830M from hy­per­ten­sion drug part­ner, claim­ing fraud

3 months ago
Pharma
Law

Siegfried’s stock slips over damp­ened sales out­look for 2025 

3 months ago
Pharma
Manufacturing

What fed­er­al job cuts at HHS mean for health tech

3 months ago
Health Tech

As part of turn­around, Sol­id Bio re­ports promis­ing ini­tial da­ta for Duchenne gene ther­a­py

3 months ago
R&D

Ar­cus touts ear­ly kid­ney can­cer da­ta as Gilead de­clines op­tion

3 months ago
Deals
R&D

Septer­na ends Phase 1 tri­al for hy­poparathy­roidism drug; Sanofi’s Mer­ilog is ap­proved

3 months ago
News Briefing

Af­ter re­search piv­ot, Bio­gen beefs up pipeline with Stoke's late-stage Dravet can­di­date

3 months ago
Deals

Hik­ma takes Amar­in's 'skin­ny la­bel' fight to the Supreme Court

3 months ago
Pharma
Law

Bavar­i­an Nordic wins FDA OK for chikun­gun­ya vac­cine in chal­lenge to Val­ne­va 

3 months ago
Pharma
FDA+

Ex­clu­sive: Sub­sense launch­es with $17M to build a non­in­va­sive brain com­put­er in­ter­face

3 months ago
Health Tech

French biotech’s top­i­cal pain treat­ment fails Phase 2 study with over­per­form­ing place­bo

3 months ago
R&D

Ex­clu­sive: Lux leads $25M Se­ries A in a Lithuan­ian start­up plot­ting US ex­pan­sion

3 months ago
Financing
Startups

Ex­clu­sive: Atom­wise, a once high-fly­ing AI start­up, taps biotech vet as CEO to lead pared-down com­pa­ny

3 months ago
People
Financing

FDA ap­proves Ono’s rare joint tu­mor drug, set­ting up bat­tle with Dai­ichi

3 months ago
Pharma
FDA+

Pain biotech Lati­go eyes up to $150M raise fol­low­ing Ver­tex's land­mark FDA nod

3 months ago
Financing
Startups

Up­dates from Wash­ing­ton; A trio of Big Phar­ma deals; What do re­cent share buy­backs mean for M&A?; and more

3 months ago
Weekly

GSK fol­lows Pfiz­er in meningo­coc­cal vac­cine race with new FDA nod

3 months ago
Pharma
FDA+

Lil­ly’s ear­ly blad­der can­cer da­ta hint at safe­ty edge over J&J’s Balver­sa

3 months ago
R&D

Health­care shake­up hits Wash­ing­ton, with cuts at CDC, NIH and oth­er agen­cies

3 months ago
FDA+
Law
First page Previous page 41424344454647 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times